"Litigation and EPO Oppositions/Appeals Related to Oxycodone" in Patents & Licensing, June 2012, Vol. 42, No. 3, 27-30
Veröffentlichung | 03.07.2012
Author(s): Dr. Th. Bausch
In the June 2012 issue of "Patents and Licensing", Dr. Thorsten Bausch of HOFFMANN EITLE's chemistry department takes a look at an interesting patent case both from an EPO and a national litigation perspective. Specifically, he reports in some detail on the litigation and EPO oppositions/appeals surrounding a controlled-release dosage form of the drug oxycodone which has kept Europe's pharma IP lawyers busy for a couple of years.
Patents & Licensing is a bimonthly publication of IP·L Communications Inc., published in the English language in Japan. HOFFMANN EITLE has been the European correspondent of Patents & Licensing for many years. Further information on Patents & Licensing can be obtained on the publishers website at www.iplcom.jp